日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting prostate tumor low-molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

靶向前列腺肿瘤低分子量酪氨酸磷酸酶进行氧化增敏治疗

Stephanie M Stanford ,Tiffany P Nguyen ,Joseph Chang ,Zixuan Zhao ,G Lavender Hackman ,Eugenio Santelli ,Colton M Sanders ,Madhusudhanarao Katiki ,Eleonora Dondossola ,Brooke L Brauer ,Michael A Diaz ,Yuan Zhan ,Sterling H Ramsey ,Philip A Watson ,Banumathi Sankaran ,Claudia Paindelli ,Vanessa Parietti ,Antonios G Mikos ,Alessia Lodi ,Aditya Bagrodia ,Andrew Elliott ,Rana R McKay ,Ramachandran Murali ,Stefano Tiziani ,Arminja N Kettenbach ,Nunzio Bottini

Phase 1 clinical trial evaluating safety, bioavailability, and gut microbiome with a combination of curcumin and ursolic acid in lipid enhanced capsules

期临床试验评估脂质增强胶囊中姜黄素和熊果酸的组合的安全性、生物利用度和肠道微生物群

Michael A Liss, Furkan Dursun, G Lavender Hackman, Mohamed I Gadallah, Achinto Saha, Chelsea A Friedman, Atul S Rathore, Preeti Chandra, James R White, Stefano Tiziani, John DiGiovanni

Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry

基于代谢组学的表型筛选,通过直接输注质谱法评估药物协同作用

Xiyuan Lu, G Lavender Hackman, Achinto Saha, Atul Singh Rathore, Meghan Collins, Chelsea Friedman, S Stephen Yi, Fumio Matsuda, John DiGiovanni, Alessia Lodi, Stefano Tiziani